期刊文献+

Notch1和c-myc在三阴乳腺癌中的表达及意义 被引量:3

Expression and significance of Notch1 and c-myc in human triple-negative breast cancer
下载PDF
导出
摘要 目的:检测三阴乳腺癌组织( TNBC)中Notch1、c-myc表达并探讨其意义。方法采用免疫组织化学S-P法检测63例TNBC组织和30例癌旁正常乳腺组织Notch1、c-myc的表达情况。结果 TNBC组织中Notch1、c-myc阳性表达定位于细胞质和细胞核,其表达率分别为71怂.43%(45/63)、69.84%(44/63),明显高于癌旁正常组织( P <0.01);63例TNBC组织中,Notch1、c-myc蛋白在组织学分级Ⅲ级阳性表达率高于Ⅰ~Ⅱ级( P <0.05),Notch1、c-myc的病理分期Ⅲ-Ⅳ期的表达率高于Ⅰ~Ⅱ期( P <0.05),Notch1、c-myc阳性表达与淋巴结转移有关( P <0.05);相关性分析显示,二者之间呈正相关( P <0.05)。结论 Notch1、c-myc在TNBC中呈明显高表达,与TNBC的发生、发展和转移密切相关。 Objective To investigate the expression of Notch 1 and c-myc in human triple-negative breast cancer (TNBC),and to explore its clinical significance .Methods The expression levels of Notch1 and c-myc were detected by immunohistochemistry ( SP ) in 63 cases of TNBC and 30 cases of cancer adjacent normal breast tissues .Results The expression of Notch1 and c-myc in human breast cancer was located in nucleus and cytoplasm .The positive expression rates of Notch1 and c-myc were 71.43%(45/63),69.84%(44/63),respectively in TNBC tissues,which were significantly higher than those in adjacent normal breast tissues ( P 〈0.05).Among 63 cases of TNBC,the positive expression rates of Notch1 and c-myc at histological grade Ⅲ were significantly higher than those at grade Ⅰ~Ⅱ( P 〈0.05).In addition,the positive expression rates of Notch1 and c-myc in stage Ⅲ~Ⅳ were significantly higher than those in stage Ⅰ~Ⅱ( P 〈0.05). Furthermore,the expression levels of Notch1 and c-myc were positively correlated to lymph node metastasis ( P 〈0.05). Conclusion Notch1 and c-myc are highly expressed in TNBC ,which is closely correlated with the occurrence ,development and metastasis of TNBC .
作者 秦景云
出处 《河北医药》 CAS 2014年第11期1614-1616,共3页 Hebei Medical Journal
关键词 三阴乳腺癌 NOTCH1 C-MYC 免疫组化 triple-negative breast cancer Notch1 c-myc immunohistochemistry
  • 相关文献

参考文献1

二级参考文献9

  • 1姜丽娜,于世英,熊慧华,张孟贤.胸苷磷酸化酶在癌组织中表达的研究[J].中华肿瘤杂志,2004,26(5):297-299. 被引量:72
  • 2王华庆.恶性肿瘤化疗方案规范[M]沈阳:辽宁科学技术出版社,200215-17.
  • 3Calliman S A,Moertel C G,Fleming T R. A comparison of three chemothempeutic regimens in the treatment of advanced pancreatic and gatric carcinoma[J].Journal of the American Medical Association,1985,(04):2061-2067.
  • 4Rekha E A,Putti T C,Abd EI-Rehim D M. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoe pithelial differentination[J].Journal of Pathology,2006.495-506.
  • 5Rugo H S,Roche H,Thomas E. Ixabepilone plus capecitabine VS capecitabine in patients with triple negative tumors:a pooled analysis of patients from two large phase Ⅲ clinical studies[A].San Antonio,Texas,USA,2008.
  • 6Spielmann M,Kalla S,Llombart-Cussac A. Activity of gemcitabine in metastatic breast cancer(MBC)patient previously treated with anthracycline-containing regimens[J].European Journal of Cancer,1997,(suppl 8):s149.
  • 7Miwa M,Ura M,Nishida M. Design of a novel oral fluoropyrimidine carbamate,capecitahine,which generates 5-fluorouracil selectively in tumors by enzymes concentrated in human liver and cancer tissue[J].European Cancer,1998,(08):1274-1281.
  • 8吴立新,黄玉霞,方月兰,夏国安.吉西他滨联合顺铂二线治疗晚期三阴乳腺癌的临床观察[J].安徽医药,2011,15(9):1149-1150. 被引量:17
  • 9郭建光,张玲慧,张连生.三阴乳腺癌生物学特征与预后的关系[J].现代中西医结合杂志,2011,20(26):3364-3365. 被引量:3

共引文献18

同被引文献58

  • 1薛敬礼,史崇敏,宋国英,章金涛,杜春燕,毕红征,王纯耀.急性肺水肿动物模型复制[J].四川动物,2006,25(3):635-637. 被引量:7
  • 2黄继汉,黄晓晖,陈志扬,郑青山,孙瑞元.药理试验中动物间和动物与人体间的等效剂量换算[J].中国临床药理学与治疗学,2004,9(9):1069-1072. 被引量:1360
  • 3董学斌,纪春岩,马道新,马榕,臧绍蕾,余海青,郭冬梅.Notch信号在人类乳腺癌中的作用[J].中华肿瘤杂志,2007,29(6):425-428. 被引量:14
  • 4Hortobagyi GN,de la Garza SJ,Pritchard K,et al.The global breast cancer burden:variations in epidemiology and survival[J].Clin Breast Cancer,2005,6(5):391-401.
  • 5Coughlin SS,Ekwueme DU.Breast cancer as a global health concerne[J].Cancer Epidemiol,2009,33(5):315-318.
  • 6Ma D,Dong X,Zang S,et al.Aberrant expression and clinical correlation of Notch signaling molecules in breast cancer of Chinese population[J].Asia Pac J Clin Oncol,2011,7(4):385-391.
  • 7Izrailit J,Reediik M.Developmental pathways in breast cancer and breast tumor-initiating cells:therapeutic implications[J].Cancer Lett,2012,317(2):115-126.
  • 8Zardawi SJ,Zardawi I,Mc Neil CM,et al.High Notch1 protein expression is an early event in breast cancer development and is associated with the Her-2 molecularsubtype[J].Histopathology,2010,56(3):286-296.
  • 9Yao K,Rizzo P,Raian P,et al.Notch-1 and notch-4 receptors as prognostic markers in breast cancer[J].Int J of Surg Pathol,2011,19(5):607-613.
  • 10Izrailit J,Berman HK,Datti A,et al.High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFpathways as fundamental Notch regulators in breast cancer[J].Proc Natl Acad Sci,2013,110(5):1714-1719.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部